# A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension

> **NCT00051194** · PHASE2 · COMPLETED · sponsor: **Alcon Research**

## Conditions studied

- Glaucoma, Open-angle
- Ocular Hypertension

## Interventions

- **DRUG:** Combination IOP Lowering Therapy

## Key facts

- **NCT ID:** NCT00051194
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-07
- **Final completion:** 2003-07
- **Target enrollment:** — (—)
- **Last updated:** 2012-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00051194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00051194, "A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00051194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*